V

Veru

D
VERU
USD
-0.01
(-1.3514%)
Market Closed
8,318.00
Volume
-0.3
EPS
-
Div Yield
-2.456667
P/E
106,860,261.60
Market Cap
Today
-1.3514%
1 Week
-3.337%
1 Month
-10.099%
6 Months
-54.658%
12 Months
-28.431%
Year To Date
1.502%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
C
CTMX
-0.005
(-0.4976%)
USD
T
TRVN
-2.02
(-44.9889%)
USD
A
AGEN
-0.385
(-8.9017%)
USD
V
VKTX
2.97
(4.5075%)
USD
A
ACOR
-0.2681
(-30.4763%)
USD
E
ESPR
-0.1
(-4.5351%)
USD
L
LPCN
-0.48
(-7.9208%)
USD
Z
ZYNE
(%)
USD
A
ALRN
-0.06
(-1.5873%)
USD

Title:
Veru

Sector:
Healthcare
Industry:
Biotechnology
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.
Do you need help or have a question?
Contact Us